Clinical Trial Update: Intervention and Mechanisms of Alanyl-Glutamine for Inflammation, Nutrition, and Enteropathy [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating alanyl-glutamine for inflammation, nutrition, and environmental enteropathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diarrhea
• Environmental Enteropathy
• Malnutrition

Drugs mentioned

• L-alanyl-L-glutamine (L-alanyl-L-glutamine)

Snippet

Sponsor: Children's Hospital Medical Center, Cincinnati | Conditions: Malnutrition, Environmental Enteropathy | Phase 3 | Status: COMPLETED